The
following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these
potential shares was antidilutive due to the Company’s net loss position even though the exercise or conversion price could be
less than the average market price of the common shares:
SCHEDULE
OF WEIGHTED AVERAGE DILUTIVE COMMON SHARES
| | |
2024 | | |
2023 | |
| | |
For the Three Months Ended | |
| | |
March 31, | |
| | |
2024 | | |
2023 | |
| Stock options | |
| 3,401,608 | | |
| 1,493,656 | |
| Warrants | |
| 3,952,840 | | |
| 4,791,075 | |
| Unvested RSUs | |
| - | | |
| 97,827 | |
| Convertible Preferred Stock | |
| 1,398,158 | | |
| 1,518,158 | |
| Total | |
| 8,752,606 | | |
| 7,900,716 | |
|